Shifting fortunes for ANZ, more of the same for CBA in 2017

Glenn Freeman  |  12/01/2017Text size  Decrease  Increase  |  

Glenn Freeman: I'm Glenn Freeman for Morningstar and I'm joined today by our Head of Australian Banking Research, David Ellis.

David, thanks for joining us today.

David Ellis: It's a pleasure, Glenn.

Freeman: Commonwealth Bank was the highest traded stock on the ASX last year. Do you expect a similar level of popularity this year?

Ellis: Yes, very much so. I mean, obviously, Commonwealth Bank is the largest stock as far as market capitalisation is concerned. It's got a relatively large retail shareholder base. Approximately 55 per cent of its shareholders are retail.

So, we'll see a lot of activity in Commonwealth Bank, but also all four major banks, because of their market size and very high weightings in retail investor portfolios that will contribute.

We might also see some buying from domestic institutional investors that are underweight the major banks and international institutional investors, again, that are very much underweight the Australian major banks.

Freeman: And on to ANZ Bank, they've announced a couple of divestments in recent times. Last year, they sold off their wealth management operation and they have just recently announced some sales in New Zealand. Can you just talk us through that and how material that is for the company?

Ellis: Yes, not a surprise. I mean, it's been well-flagged. ANZ CEO, Shayne Elliott, started on the first of January 2016 and during 2016 undertook a number of major structural changes, and restructured the business and sold assets, and this is a follow-on from that and I expect we'll see more of the same in 2017 and possibly into 2018.

It's interesting that ANZ has changed from being the worst-performing bank of the four major banks at the beginning of 2016 to now one of the best-performing, as far as share price is concerned. So, it's turned around significantly.

And it's now got the highest capital levels of the four major banks which we may see--ironically, we may see capital management initiatives from ANZ in 2018-2019. So, we may see share buybacks or potentially special dividends from ANZ in 2018 and/or 2019.

Freeman: And lastly, David, what do you see as the biggest opportunities for banks in 2017 and some of the biggest challenges?

Ellis: I started off by saying I expect modest to a moderate earnings growth in 2017. Well, it's possible the banks will surprise on the upside. So, earnings growth could be higher than I'm forecasting. The banks are so big, the four major banks are so big that their profits for 2017 are pretty baked in, locked in now even though there is still a number of months to go.
So, we're seeing greater economic optimism coming out of the US following the US presidential elections in early November, and I'm hoping that that will extend globally and the Australian banks will benefit from that. So, there's upside there.

There's upside from a slightly better economic outlook in Australia than currently is anticipated. Bad debts could be lower than a lot of people fear. House prices could hold up--or I expect they will hold up in 2017. So, I'm not expecting any major problems there.

The big focus, as I said earlier, was on capital and dividends. So, the international banking regulator is expected to announce tougher capital rules and the Australian regulator, APRA, will likely pass those rules through to the Australian banks.

But there's now a greater expectation that those rules have been watered down and that the four major Australian banks are already well-capitalised with strong balance sheets, strong liquidity and funding. So, there's less pressure on capital raises in 2017 and I don't expect there will be--there will be no need for any one-off capital raisings.

And importantly, I think, their dividends will not be cut in 2017 and I'm expecting a modest increase in CBA's dividend and flat dividends for ANZ, for NAB and for Westpac in 2017.

Freeman: Thanks very much for your time today, David.

Ellis: Pleasure, Glenn. Thank you.

Freeman: I'm Glenn Freeman for Morningstar. Thanks for watching.

Video Archive...

Shifting fortunes for ANZ, more of the same for CBA in 2017
12/01/2017  Australian banks are well-positioned as they head into 2017, with ANZ moving from least profitable in 2016 to become one of the sector's top performers and CBA remaining an investor favourite.
Is Trump a threat to emerging markets?
12/01/2017  Is President Donald Trump a threat to emerging market returns? Paul Jackson from the UK-based Source ETF considers the outlook for sector and where investors can find the best opportunities.
Platinum, Aussie banks and Peter Warnes among top interviews of 2016
22/12/2016  We look back on some of our most notable interviews of the year, as Morningstar analysts and external experts helped us delve into some of the biggest events that shaped Australian and global markets in 2016.
Oil price finds sweet spot, while mining hits rock bottom
20/12/2016  The rise in oil prices should see improved performances from Australian producers in 2017, while mining services companies will continue to struggle amid weaker Chinese demand, says Morningstar equity analyst Mark Taylor.
How Greek mythology can make you a better investor
07/12/2016  Don't be over confident or follow the herd, and like Odysseus, learn to have yourself "tied to the mast" when it comes to long-term investing.
Supermarket headwinds prompt fair value cut for majors
06/12/2016  Growing competitive pressures and a declining revenue outlook for Australia's two grocery giants now look to be part of a longer-term, structural shift.
What returns should you expect from markets?
01/12/2016  As market risks rise, investors must adjust their profit expectations--gone are the days of 8 per cent returns. But there are still growth opportunities out there if you know where to look.
Why healthcare stocks got a bump from Trump
28/11/2016  Australian healthcare and pharmaceutical companies continue to enjoy a purple patch, and for various reasons including the recent US election result, explains Morningstar's healthcare equities analyst Chris Kallos.
Equity and hybrid investors react as bond prices tumble
24/11/2016  The negative correlation between bonds and equities is reasserting itself following the US election of Donald Trump, according to John Likos, Morningstar's senior credit analyst.
2 global themes that are finding favour among ETF investors
15/11/2016  Australian retail investors are increasingly turning to ETFs for specific tactical exposures to global themes, particularly in the context of large-scale market events such as US election 2016.
Maintain discipline and stick to fundamentals when selecting stocks
14/11/2016  Steer clear of fads, maintain a disciplined approach and focus on company fundamentals in building and maintaining your investment portfolio, says Anton Tagliaferro, investment director, Investors Mutual
How Trump could impact economic growth
10/11/2016  Slowdowns in trade and immigration could hold back the US, and infrastructure spending could boost GDP, but it's too early to make any major changes to our economic forecast, says Morningstar's Bob Johnson.
President Trump: What should you do?
10/11/2016  Donald Trump has beaten Hillary Clinton to become the 45th US president. What should investors do?
Software companies worth watching amid tech deployment phase
08/11/2016  Kate Howitt, portfolio manager at Fidelity International discusses some of the core phases in technological disruption and identifies software companies among those currently presenting opportunities.
Kerr Neilson hot, cold and tepid on Europe, US and China
07/11/2016  Platinum co-founder and CEO Kerr Neilson explains his views on the major global markets and outlines where he sees opportunities--and where he doesn't.
Is Inghams a moat-worthy investment?
02/11/2016  Morningstar's Ravi Reddy discusses the upcoming float of poultry product producer Inghams, and whether it's in investors' interests to subscribe for shares in the IPO.
3 best ideas in healthcare
26/10/2016  Morningstar's Chris Kallos looks at some of the most compelling ideas in Australian healthcare, while also reaffirming the importance of the uncertainty rating and how it pertains to the sector.
Exercise caution and let some cash build
24/10/2016  Morningstar's Peter Warnes provides a near-term outlook for equities markets, while also sharing his thoughts on the upcoming Ingham's IPO.
Bogle forecasts low stock and bond market returns
21/10/2016  Warning of "much lower market returns" ahead, Vanguard founder Jack Bogle urges investors to seek low-cost investment products. From Morningstar US.
Finding the right flavour ETF amid expanding ETP menu
13/10/2016  From a relatively vanilla selection of exchange-traded funds (ETFs) on offer in the early 2000s, Australian investors can now choose from a wide range of exchange-traded products to suit various tastes.